Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - TAX PROVISION
Tax Provision FATE - Fate Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR